AI Article Synopsis

  • The study aimed to assess health-related quality of life (HRQOL) among diffuse large B cell lymphoma (DLBCL) survivors across different age groups and compare it with a normative population.
  • Younger DLBCL survivors (ages 18-59) exhibited better physical functioning and quality of life than older survivors (ages 76-85), but faced more financial issues.
  • While younger survivors had poorer cognitive and social functioning compared to their normative peers, the negative HRQOL impact of DLBCL was significantly greater for them than older survivors, indicating that age plays a key role in the quality of life outcomes.

Article Abstract

The objective of this study was to compare health-related quality of life (HRQOL) between diffuse large B cell lymphoma (DLBCL) survivors of different age categories (18-59/60-75/76-85 years) and to compare their HRQOL with an age- and sex-matched normative population. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with DLBCL from 1999 to 2010. Patients (n = 363) were invited to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire, and 307 survivors responded (85 %). Data from an age- and sex-matched normative population (n = 596) were used for comparison. DLBCL survivors aged 18-59 years scored better on physical functioning, quality of life, appetite loss and constipation than survivors of 76-85 years old (all p < 0.05). Financial problems more often occurred in survivors aged 18-59 years compared to survivors of 76-85 years old (p < 0.01). Compared to the normative population, DLBCL survivors aged 18-59 years showed worse scores on cognitive and social functioning and on dyspnea and financial problems (p < 0.01, large- and medium-size effects). In survivors of the other age categories, only differences with trivial or small-size effects were found. Although younger DLBCL survivors have better HRQOL than older survivors, the differences found between younger survivors and normative population were the largest. This suggests that having DLBCL has a greater impact on younger than older survivors and that the worse HRQOL observed in older DLBCL survivors in comparison with younger survivors is caused mostly by age itself and not by the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1980-1DOI Listing

Publication Analysis

Top Keywords

quality life
16
normative population
12
diffuse large
8
large cell
8
cell lymphoma
8
dlbcl survivors
8
age- sex-matched
8
sex-matched normative
8
survivors
5
quality
4

Similar Publications

Background: Wearable activity-measurement devices are increasingly popular among the public, but there is little information regarding their use among patients undergoing sports medicine procedures. The purpose of this study was to compare accelerometer-measured data with traditional patient-reported measures and to determine the trajectory of physical activity from before surgery to 1 year after anterior cruciate ligament reconstruction.

Materials And Methods: Adult patients undergoing primary anterior cruciate ligament reconstruction were enrolled in this prospective cohort pilot study.

View Article and Find Full Text PDF

Background: Psoriasis is an inflammatory disease primarily treated through molecular-targeted therapies. However, emerging evidence suggests that dietary interventions may also play a role in managing inflammation associated with this condition. The Mediterranean diet (MedDiet), prevalent in southern European countries, has been widely recognized for its ability to reduce cardiovascular mortality, largely due to its anti-inflammatory properties.

View Article and Find Full Text PDF

Purpose: Mobocertinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that targets exon 20 insertion (ex20ins) mutations in non-small cell lung cancer (NSCLC). This open-label, phase III trial (EXCLAIM-2: ClinicalTrials.gov identifier: NCT04129502) compared mobocertinib versus platinum-based chemotherapy as first-line treatment of ex20ins+ advanced/metastatic NSCLC.

View Article and Find Full Text PDF

Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life.

Rambam Maimonides Med J

January 2025

Department of Neurosurgery, South Kazakhstan Medical Academy, Shymkent, Republic of Kazakhstan.

Viral hepatitis, primarily caused by hepatitis B virus and hepatitis C virus, is widely recognized for its impact on liver function, but emerging evidence suggests it also affects cognitive function. This review explores the causes, manifestations, and impact of cognitive impairments in patients with viral hepatitis, to better understand this often-overlooked aspect of the disease. A literature review was conducted, focusing on studies published in PubMed up to August 2024.

View Article and Find Full Text PDF

This study aimed to understand the impact of municipal basic sanitation policies and plans on the rate of access to drinking water and sewage services. For this, data were collected from the 853 municipalities of Minas Gerais regarding the provision of sanitation, as well as socioeconomic, quality of life and demographic indicators, treated with the t-test techniques for differences between means and Propensity Score Matching. The results revealed the need for greater sanitation planning in the state since a significant portion of municipalities do not have formal planning instruments for the sector.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!